Cargando…
An Update on the Use of Animal Models in Diabetic Nephropathy Research
In the current review, we discuss limitations and recent advances in animal models of diabetic nephropathy (DN). As in human disease, genetic factors may determine disease severity with the murine FVB and DBA/2J strains being more susceptible to DN than C57BL/6J mice. On the black and tan, brachyuri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729785/ https://www.ncbi.nlm.nih.gov/pubmed/26814757 http://dx.doi.org/10.1007/s11892-015-0706-2 |
_version_ | 1782412293127012352 |
---|---|
author | Betz, Boris Conway, Bryan R. |
author_facet | Betz, Boris Conway, Bryan R. |
author_sort | Betz, Boris |
collection | PubMed |
description | In the current review, we discuss limitations and recent advances in animal models of diabetic nephropathy (DN). As in human disease, genetic factors may determine disease severity with the murine FVB and DBA/2J strains being more susceptible to DN than C57BL/6J mice. On the black and tan, brachyuric (BTBR) background, leptin deficient (ob/ob) mice develop many of the pathological features of human DN. Hypertension synergises with hyperglycemia to promote nephropathy in rodents. Moderately hypertensive endothelial nitric oxide synthase (eNOS(−/−)) deficient diabetic mice develop hyaline arteriosclerosis and nodular glomerulosclerosis and induction of renin-dependent hypertension in diabetic Cyp1a1mRen2 rats mimics moderately severe human DN. In addition, diabetic eNOS(−/−) mice and Cyp1a1mRen2 rats recapitulate many of the molecular pathways activated in the human diabetic kidney. However, no model exhibits all the features of human DN; therefore, researchers should consider biochemical, pathological, and transcriptomic data in selecting the most appropriate model to study their molecules and pathways of interest. |
format | Online Article Text |
id | pubmed-4729785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-47297852016-02-09 An Update on the Use of Animal Models in Diabetic Nephropathy Research Betz, Boris Conway, Bryan R. Curr Diab Rep Microvascular Complications—Nephropathy (AP Maxwell, Section Editor) In the current review, we discuss limitations and recent advances in animal models of diabetic nephropathy (DN). As in human disease, genetic factors may determine disease severity with the murine FVB and DBA/2J strains being more susceptible to DN than C57BL/6J mice. On the black and tan, brachyuric (BTBR) background, leptin deficient (ob/ob) mice develop many of the pathological features of human DN. Hypertension synergises with hyperglycemia to promote nephropathy in rodents. Moderately hypertensive endothelial nitric oxide synthase (eNOS(−/−)) deficient diabetic mice develop hyaline arteriosclerosis and nodular glomerulosclerosis and induction of renin-dependent hypertension in diabetic Cyp1a1mRen2 rats mimics moderately severe human DN. In addition, diabetic eNOS(−/−) mice and Cyp1a1mRen2 rats recapitulate many of the molecular pathways activated in the human diabetic kidney. However, no model exhibits all the features of human DN; therefore, researchers should consider biochemical, pathological, and transcriptomic data in selecting the most appropriate model to study their molecules and pathways of interest. Springer US 2016-01-27 2016 /pmc/articles/PMC4729785/ /pubmed/26814757 http://dx.doi.org/10.1007/s11892-015-0706-2 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Microvascular Complications—Nephropathy (AP Maxwell, Section Editor) Betz, Boris Conway, Bryan R. An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title_full | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title_fullStr | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title_full_unstemmed | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title_short | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
title_sort | update on the use of animal models in diabetic nephropathy research |
topic | Microvascular Complications—Nephropathy (AP Maxwell, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729785/ https://www.ncbi.nlm.nih.gov/pubmed/26814757 http://dx.doi.org/10.1007/s11892-015-0706-2 |
work_keys_str_mv | AT betzboris anupdateontheuseofanimalmodelsindiabeticnephropathyresearch AT conwaybryanr anupdateontheuseofanimalmodelsindiabeticnephropathyresearch AT betzboris updateontheuseofanimalmodelsindiabeticnephropathyresearch AT conwaybryanr updateontheuseofanimalmodelsindiabeticnephropathyresearch |